These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12183858

  • 1. Use of statin drugs in women.
    LaRosa JC.
    J Hypertens Suppl; 2002 May; 20(2):S70-2. PubMed ID: 12183858
    [Abstract] [Full Text] [Related]

  • 2. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators.
    Am Heart J; 2003 Apr 04; 145(4):643-51. PubMed ID: 12679760
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P.
    Clin Ther; 2007 Feb 04; 29(2):253-60. PubMed ID: 17472818
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 04; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 14. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S, Ridker PM.
    Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of postmenopausal hormone therapy on cardiovascular risk.
    Rossouw JE.
    J Hypertens Suppl; 2002 May 16; 20(2):S62-5. PubMed ID: 12183856
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke.
    Ovbiagele B, Saver JL, Bang H, Chambless LE, Nassief A, Minuk J, Toole JF, Crouse JR, VISP Study Investigators.
    Neurology; 2006 Apr 25; 66(8):1164-70. PubMed ID: 16636231
    [Abstract] [Full Text] [Related]

  • 19. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct 11; 149(41):44-5. PubMed ID: 17992793
    [No Abstract] [Full Text] [Related]

  • 20. What do the statins tell us?
    LaRosa JC.
    Am Heart J; 2002 Dec 11; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.